Nuventra Pharma Sciences is now Allucent. Learn more here.

Strategic guidance from
proven professionals

Brandon Burch, Ph.D.

Director, Scientific Writing & Regulatory Affairs

Dr. Burch has been with Nuventra since May 2014 with a primary focus on regulatory affairs, medical and scientific writing, and project management, and currently oversees Nuventra’s Regulatory Affairs and Scientific Writing department. Dr. Burch has participated in numerous IND, NDA (505(b)(1) and 505(b)(2)), and BLA submissions across a multitude of drug classes, routes of administration, and therapeutic areas. Dr. Burch’s experience includes overall regulatory strategy; client representation at FDA meetings; on-site assessments and gap analyses for client development programs; authoring clinical, nonclinical, quality (i.e., Chemistry, Manufacturing, and Controls), and administrative modules of regulatory submissions; and authoring clinical study reports, manuscripts, and a diverse array of other regulatory, scientific, and technical documents.


  • Post-doctoral Fellowship, Department of Medicine (Infectious Diseases)
    • University of North Carolina, Chapel Hill, NC
  • Doctor of Philosophy, Genetics and Molecular Biology
    • University of North Carolina, Chapel Hill, NC
  • Master of Science, Biology (Cell Biology Concentration)
    • East Carolina University, Greenville, NC
  • Bachelor of Science, Biology
    • University of North Carolina, Chapel Hill, NC